Oroxylin A prevents alcohol-induced hepatic steatosis through inhibition of hypoxia inducible factor 1alpha
Authors:
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 285, 14-20
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31571455, 31401210, 31600653, 81600483, 81270514)
- Open Project Program of Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica (JKLPSE 201502)
- Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 20 references indexed in Scilit:
- Prevalence and Natural History of Alcoholic Liver DiseaseClinics in Liver Disease, 2012
- Source and characterization of hepatic macrophages in acetaminophen-induced acute liver failure in humansHepatology, 2012
- HIF-1α is a major and complex player in alcohol induced liver diseasesJournal of Hepatology, 2012
- Pathways of liver injury in alcoholic liver diseaseJournal of Hepatology, 2011
- Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding modelJournal of Hepatology, 2006
- Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosisAlcohol, 2004
- Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alphaAlcohol, 2004
- The role of hypoxia in the pathogenesis of alcoholic liver diseaseHepatology Research, 2004
- Hepatic steatosis: Innocent bystander or guilty party?Hepatology, 1998
- Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivoHepatology, 1997